Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria A. Mabunay"'
Autor:
Bipin Sethi, Khalid Al-Rubeaan, Mustafa Unubol, Maria A. Mabunay, Baptiste Berthou, Valerie Pilorget, Shireene R. Vethakkan, Gustavo Frechtel
Publikováno v:
Diabetes therapy : research, treatment and education of diabetes and related disorders.
The efficacy and safety of switching to insulin glargine 300 U/mL (Gla-300) in type 2 diabetes mellitus (T2DM) uncontrolled on basal insulin (BI) has been demonstrated in the North American and Western European populations; however, there is limited
Autor:
Gagik R. Galstyan, Amir Tirosh, Hernando Vargas-Uricoechea, Maria Aileen Mabunay, Mathieu Coudert, Mubarak Naqvi, Valerie Pilorget, Niaz Khan
Publikováno v:
Diabetes therapy : research, treatment and education of diabetes and related disorders. 13(6)
The clinical benefits of insulin glargine 300 U/mL (Gla-300) have been confirmed in randomised clinical trials (EDITION programme and BRIGHT) and real-world studies in the USA and Western Europe. ATOS evaluated the real-world effectiveness and safety
Autor:
Jung Fu Chen, Su-Yen Goh, Maria Aileen Mabunay, Wing Bun Chan, Sony Wibisono Mudjanarko, Pongamorn Bunnag, Shailendra Bajpai, Iris Thiele Isip-Tan, Thi Thanh Huyen Vu
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Basal insulin therapy can improve glycemic control in people with type 2 diabetes. However, timely initiation, optimal titration, and proper adherence to prescribed basal insulin regimens are necessary to achieve optimal glycemic control. Even so, gl
Autor:
Shailendra Bajpai, Shih-Tzer Tsai, Zanariah Hussein, Chaicharn Deerochanawong, Man Wo Tsang, I. Made Pande Dwipayana, Maria Aileen Mabunay, Reynaldo Rosales
Publikováno v:
Diabetes Therapy
Various data have demonstrated inadequate glycemic control amongst Asians with type 2 diabetes mellitus (T2DM), possibly on account of suboptimal titration of basal insulin—an issue which needs to be further examined. Here we review the available g